ORIENT_DENTAL_LABORATORY_ - Accounts

Company Registration No. 3471385 (England and Wales)
ORIENT DENTAL LABORATORY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2017
PAGES FOR FILING WITH REGISTRAR
ORIENT DENTAL LABORATORY LTD
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7
ORIENT DENTAL LABORATORY LTD
STATEMENT OF FINANCIAL POSITION
AS AT
30 NOVEMBER 2017
30 November 2017
- 1 -
2017
2016
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
3
23,094
13,972
Current assets
Inventories
3,438
8,524
Trade and other receivables
4
116,146
117,251
Cash and cash equivalents
35
-
119,619
125,775
Current liabilities
5
(87,278)
(59,826)
Net current assets
32,341
65,949
Total assets less current liabilities
55,435
79,921
Non-current liabilities
6
(17,186)
(6,699)
Provisions for liabilities
(1,014)
(2,120)
Net assets
37,235
71,102
Equity
Called up share capital
7
100
100
Retained earnings
37,135
71,002
Total equity
37,235
71,102

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 30 November 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.

ORIENT DENTAL LABORATORY LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
30 NOVEMBER 2017
30 November 2017
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 24 August 2018 and are signed on its behalf by:
Mr S Low
Director
Company Registration No. 3471385
ORIENT DENTAL LABORATORY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2017
- 3 -
1
Accounting policies
Company information

Orient Dental Laboratory Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Almswood House, 93 High Street, Evesham, Worcestershire, United Kingdom, WR11 4DU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

These financial statements for the year ended 30 November 2017 are the first financial statements of Orient Dental Laboratory Ltd prepared in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of transition to FRS 102 was 1 December 2015. The reported financial position and financial performance for the previous period are not affected by the transition to FRS 102.

1.2
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

1.3
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
over 10 years
Fixtures, fittings & equipment
25% reducing balance
Computer equipment
25% reducing balance
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of non-current assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

ORIENT DENTAL LABORATORY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2017
1
Accounting policies
(Continued)
- 4 -
1.5
Inventories

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ORIENT DENTAL LABORATORY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2017
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to the income statement so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 12 (2016 - 13).

ORIENT DENTAL LABORATORY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2017
- 6 -
3
Property, plant and equipment
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 December 2016
31,617
84,253
115,870
Additions
-
18,285
18,285
Disposals
-
(9,887)
(9,887)
At 30 November 2017
31,617
92,651
124,268
Depreciation and impairment
At 1 December 2016
31,617
70,281
101,898
Depreciation charged in the year
-
7,843
7,843
Eliminated in respect of disposals
-
(8,567)
(8,567)
At 30 November 2017
31,617
69,557
101,174
Carrying amount
At 30 November 2017
-
23,094
23,094
At 30 November 2016
-
13,972
13,972

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.

2017
2016
£
£
Motor vehicles
13,714
-
13,714
-
Depreciation charge for the year in respect of leased assets
4,571
-
4
Trade and other receivables
2017
2016
Amounts falling due within one year:
£
£
Trade receivables
62,297
64,558
Other receivables
53,849
52,693
116,146
117,251
ORIENT DENTAL LABORATORY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2017
- 7 -
5
Current liabilities
2017
2016
£
£
Bank loans and overdrafts
22,122
26,486
Trade payables
11,981
2,775
Corporation tax
40,332
34,792
Other taxation and social security
5,518
4,822
Other payables
7,325
(9,049)
87,278
59,826
6
Non-current liabilities
2017
2016
£
£
Bank loans and overdrafts
3,412
6,699
Other payables
13,774
-
17,186
6,699
7
Called up share capital
2017
2016
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary shares of £1 each
100
100
100
100
8
Directors' transactions

Dividends totalling £24,100 (2016 - £32,250) were paid in the year in respect of shares held by the company's directors.

Interest free loans have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts repaid
Closing balance
£
£
£
Mr S K Low
-
9,988
(9,988)
-
9,988
(9,988)
-
2017-11-302016-12-01falseCCH SoftwareCCH Accounts Production 2018.200Provision of dental laboratory products and services.
Mr G LowMr S K LowMr S LowMr J LowMrs C Low
34713852016-12-012017-11-3034713852017-11-3034713852016-11-303471385core:OtherPropertyPlantEquipment2017-11-303471385core:OtherPropertyPlantEquipment2016-11-303471385core:CurrentFinancialInstruments2017-11-303471385core:CurrentFinancialInstruments2016-11-303471385core:Non-currentFinancialInstruments2017-11-303471385core:Non-currentFinancialInstruments2016-11-303471385core:ShareCapital2017-11-303471385core:ShareCapital2016-11-303471385core:RetainedEarningsAccumulatedLosses2017-11-303471385core:RetainedEarningsAccumulatedLosses2016-11-303471385core:ShareCapitalOrdinaryShares2017-11-303471385core:ShareCapitalOrdinaryShares2016-11-303471385bus:Director32016-12-012017-11-303471385core:LandBuildingscore:LeasedAssetsHeldAsLessee2016-12-012017-11-303471385core:FurnitureFittings2016-12-012017-11-303471385core:ComputerEquipment2016-12-012017-11-303471385core:MotorVehicles2016-12-012017-11-303471385core:LandBuildings2016-11-303471385core:OtherPropertyPlantEquipment2016-11-3034713852016-11-303471385core:LandBuildings2017-11-303471385core:OtherPropertyPlantEquipment2016-12-012017-11-303471385core:MotorVehicles2017-11-303471385bus:OrdinaryShareClass12016-12-012017-11-303471385bus:OrdinaryShareClass12017-11-303471385bus:PrivateLimitedCompanyLtd2016-12-012017-11-303471385bus:FRS1022016-12-012017-11-303471385bus:AuditExemptWithAccountantsReport2016-12-012017-11-303471385bus:SmallCompaniesRegimeForAccounts2016-12-012017-11-303471385bus:Director12016-12-012017-11-303471385bus:Director22016-12-012017-11-303471385bus:Director42016-12-012017-11-303471385bus:CompanySecretary12016-12-012017-11-303471385bus:FullAccounts2016-12-012017-11-30xbrli:purexbrli:sharesiso4217:GBP